Imaging for Response Assessment in Cancer Clinical Trials

The use of biomarkers is integral to the routine management of cancer patients, including diagnosis of disease, clinical staging and response to therapeutic intervention. Advanced imaging metrics with computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET)...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Seminars in nuclear medicine 2020-11, Vol.50 (6), p.488-504
Hauptverfasser:	Sorace, Anna G., Elkassem, Asser A., Galgano, Samuel J., Lapi, Suzanne E., Larimer, Benjamin M., Partridge, Savannah C., Quarles, C. Chad, Reeves, Kirsten, Napier, Tiara S., Song, Patrick N., Yankeelov, Thomas E., Woodard, Stefanie, Smith, Andrew D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Trials as Topic Diagnostic Imaging - methods Humans Neoplasms - diagnostic imaging Neoplasms - therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!